Phase 3 Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary Hyperparathyroidism

Clinical trial NCT03280264 · COMPLETED

Trial details

NCT number: NCT03280264
Sponsor: Kyowa Kirin Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Parathyroid Carcinoma Primary Hyperparathyroidism

Start date: 2017-08-30
Primary completion: 2019-04-09
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.